Observational study / 2004
Being an equol producer was linked to lower rates of prostate cancer in Japanese and Korean case-control groups.
Researchers compared the percentage of equol producers between prostate cancer patients and controls in Japan, Korea, and the United States. The percentage of equol producers among patients versus controls was 29% and 46% in Japan (P = 0.004) and 30% and 59% in Korea (P = 0.001). Among Americans, active isoflavone levels were markedly lower and the percentage of equol producers was lower (17% for patients and 14% for controls) compared to Japanese and Korean participants.
Shows an association, not proof of cause and effect.
- Study type
- Case-control study
- Who was studied
- 295 subjects in Japan (133 patients, 162 controls), 122 in Korea (61 patients, 61 controls), and 45 in the United States (24 patients, 21 controls)
- What was measured
- Percentage of equol producers and active isoflavone levels
THE PAPER
Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.
Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ. Jpn J Clin Oncol, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.